This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Aic246 Ag & Co. Kg. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dorothea Hohmann: Pharmaceutical Composition Inventor
Introduction
Dorothea Hohmann is an inventor associated with Hamburg, Germany, and Aic246 AG & Co. KG. Her patent work concerns pharmaceutical compositions designed to support antiviral treatment and prevention.
Latest Patents
Hohmann is named on 1 patent: “Pharmaceutical compositions comprising 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate and sodium ions.” The invention describes stable compositions containing the specified compound and sodium ions, formulated essentially without complexing solubilizing agents such as polyethylene glycol, cyclodextrin, lysine, or arginine, particularly HPBCD. It also covers methods for preparing the compositions and their use in treating or preventing illnesses, especially as an antiviral approach against cytomegaloviruses.
Career Highlights
The patent reflects Hohmann’s contribution to pharmaceutical formulation research, with an emphasis on stability and reducing reliance on complexing solubilizing agents. The disclosed work also connects formulation development with potential antiviral applications.
Collaborations
Hohmann’s listed coworkers include Jessica Redmer and Jordi Carles Cerón Bertran. The patent is associated with Aic246 AG & Co. KG.
Conclusion
Dorothea Hohmann’s recorded patent contribution focuses on a stable pharmaceutical composition and its potential use in antiviral treatment and prevention, particularly against cytomegaloviruses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile